StockStory Sees Pfizer Strength, Flags Danaher and Integer Risks
The publisher points to Pfizer’s revenue scale and improving adjusted operating profits, while citing growth and margin concerns at two peers.
Makkler Newsroom · Oct 7, 12:23 PM · 1 min read